Roger L. Papke

9.0k total citations
185 papers, 7.5k citations indexed

About

Roger L. Papke is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Roger L. Papke has authored 185 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 173 papers in Molecular Biology, 63 papers in Cellular and Molecular Neuroscience and 22 papers in Pharmacology. Recurrent topics in Roger L. Papke's work include Nicotinic Acetylcholine Receptors Study (166 papers), Receptor Mechanisms and Signaling (132 papers) and Ion channel regulation and function (56 papers). Roger L. Papke is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (166 papers), Receptor Mechanisms and Signaling (132 papers) and Ion channel regulation and function (56 papers). Roger L. Papke collaborates with scholars based in United States, Germany and Italy. Roger L. Papke's co-authors include Nicole A. Horenstein, Clare Stokes, Edwin M. Meyer, Steve Heinemann, Dustin K. Williams, Merouane Bencherif, Jingyi Wang, Patrick M. Lippiello, Christopher M. de Fiebre and Jeffrey S. Thinschmidt and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and SHILAP Revista de lepidopterología.

In The Last Decade

Roger L. Papke

182 papers receiving 7.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger L. Papke United States 50 6.4k 2.3k 1.3k 571 493 185 7.5k
Ronald J. Lukas United States 48 5.5k 0.9× 2.2k 0.9× 1.1k 0.8× 379 0.7× 810 1.6× 170 7.0k
Cecilia Gotti Italy 49 8.2k 1.3× 3.5k 1.5× 1.5k 1.1× 335 0.6× 840 1.7× 182 9.6k
Francesco Clementi Italy 41 5.0k 0.8× 2.2k 0.9× 828 0.6× 198 0.3× 546 1.1× 117 5.9k
Nicoletta Galeotti Italy 43 2.6k 0.4× 1.6k 0.7× 753 0.6× 318 0.6× 1.5k 3.1× 239 6.1k
Steve Heinemann United States 38 6.6k 1.0× 3.8k 1.6× 725 0.5× 205 0.4× 513 1.0× 63 8.0k
Edna F. R. Pereira United States 47 6.3k 1.0× 3.7k 1.6× 2.7k 2.0× 561 1.0× 735 1.5× 106 10.3k
Joseph W. Lynch Australia 41 3.8k 0.6× 3.2k 1.4× 338 0.3× 199 0.3× 405 0.8× 122 5.9k
Keith Williams United States 40 4.1k 0.6× 4.3k 1.8× 492 0.4× 356 0.6× 403 0.8× 98 6.3k
Carlos Fernando Mello Brazil 41 1.7k 0.3× 1.4k 0.6× 588 0.4× 291 0.5× 858 1.7× 164 4.6k
J. Michael McIntosh United States 76 16.4k 2.6× 7.4k 3.1× 2.2k 1.6× 450 0.8× 1.3k 2.7× 313 18.5k

Countries citing papers authored by Roger L. Papke

Since Specialization
Citations

This map shows the geographic impact of Roger L. Papke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger L. Papke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger L. Papke more than expected).

Fields of papers citing papers by Roger L. Papke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger L. Papke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger L. Papke. The network helps show where Roger L. Papke may publish in the future.

Co-authorship network of co-authors of Roger L. Papke

This figure shows the co-authorship network connecting the top 25 collaborators of Roger L. Papke. A scholar is included among the top collaborators of Roger L. Papke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger L. Papke. Roger L. Papke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Papke, Roger L., et al.. (2024). Investigating the role of nicotinic acetylcholine receptors in menthol's effects in mice. Drug and Alcohol Dependence. 257. 111262–111262. 1 indexed citations
2.
Papke, Roger L.. (2024). Functions and pharmacology of α2β2 nicotinic acetylcholine receptors; in and out of the shadow of α4β2 nicotinic acetylcholine receptors. Biochemical Pharmacology. 225. 116263–116263. 2 indexed citations
3.
Richter, Katrin, et al.. (2023). Pharmacological profiles and anti-inflammatory activity of pCN-diEPP and mCN-diEPP, new alpha9alpha10 nicotinic receptor ligands. Neuropharmacology. 240. 109717–109717. 7 indexed citations
4.
Stokes, Clare, José A. Pino, Gonzalo E. Torres, et al.. (2022). Betel quid: New insights into an ancient addiction. Addiction Biology. 27(5). e13223–e13223. 12 indexed citations
5.
Gulsevin, Alican, Roger L. Papke, Clare Stokes, et al.. (2021). The Allosteric Activation of α7 nAChR by α-Conotoxin MrIC Is Modified by Mutations at the Vestibular Site. Toxins. 13(8). 555–555. 7 indexed citations
6.
Horenstein, Nicole A., Clare Stokes, & Roger L. Papke. (2021). Sulfonium Ligands of the α7 nAChR. Molecules. 26(18). 5643–5643. 3 indexed citations
7.
Corrie, Lu Wen-Chi, Clare Stokes, Jenny L. Wilkerson, et al.. (2020). Nicotinic Acetylcholine Receptor Accessory Subunits Determine the Activity Profile of Epibatidine Derivatives. Molecular Pharmacology. 98(4). 328–342. 8 indexed citations
8.
Stokes, Clare, Brendan M. Duggan, Katarzyna Kaczanowska, et al.. (2019). Synthesis, Pharmacological Characterization, and Structure–Activity Relationships of Noncanonical Selective Agonists for α7 nAChRs. Journal of Medicinal Chemistry. 62(22). 10376–10390. 18 indexed citations
9.
Papke, Roger L., Clare Stokes, Pretal P. Muldoon, & M. Imad Damaj. (2013). Similar activity of mecamylamine stereoisomers in vitro and in vivo. European Journal of Pharmacology. 720(1-3). 264–275. 20 indexed citations
13.
Papke, Roger L., et al.. (2011). The twin drug approach for novel nicotinic acetylcholine receptor (nAChR) ligands: Synthesis and structure–affinity relationships. Biochemical Pharmacology. 82(8). 1028–1028. 3 indexed citations
14.
Murray, Teresa A., Daniel Bertrand, Roger L. Papke, et al.. (2011). α7β2 Nicotinic Acetylcholine Receptors Assemble, Function, and Are Activated Primarily via Their α7-α7 Interfaces. Molecular Pharmacology. 81(2). 175–188. 54 indexed citations
15.
Horenstein, Nicole A., Thomas J. McCormack, Clare Stokes, Ke Ren, & Roger L. Papke. (2006). Reversal of Agonist Selectivity by Mutations of Conserved Amino Acids in the Binding Site of Nicotinic Acetylcholine Receptors. Journal of Biological Chemistry. 282(8). 5899–5909. 26 indexed citations
16.
Papke, Roger L.. (2005). Estimation of both the potency and efficacy of α7 nAChR agonists from single-concentration responses. Life Sciences. 78(24). 2812–2819. 34 indexed citations
18.
Papke, Roger L., Benjamin A. Horenstein, & Andon N. Placzek. (2001). Inhibition of Wild-Type and Mutant Neuronal Nicotinic Acetylcholine Receptors by Local Anesthetics. Molecular Pharmacology. 60(6). 1365–1374. 16 indexed citations
19.
Webster, Jeffrey C., et al.. (1999). Antagonist activities of mecamylamine and nicotine show reciprocal dependence on beta subunit sequence in the second transmembrane domain. British Journal of Pharmacology. 127(6). 1337–1348. 49 indexed citations
20.
Papke, Roger L., et al.. (1999). Subtype-Specific Effects of Lithium on Glutamate Receptor Function. Journal of Neurophysiology. 81(4). 1506–1512. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026